We are a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, which we collectively refer to as autoimmune diseases.
$19.00 - $21.00
October 3, 2019
GOLDMAN SACHS & CO. LLC ,MORGAN STANLEY & CO. LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Viela Bio IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277